News about Digitalization

Qure.ai Partners with Microsoft to Expand Lung Cancer AI Access in the US

Qure.ai has partnered with Microsoft to broaden access to its advanced lung cancer detection and management AI suite across the US. The collaboration integrates Qure.ai’s LLM- and agentic AI–driven tools into clinical workflows, helping radiology and pulmonology teams accelerate patient detection, diagnosis, and treatment pathways.

Digitalization | 20/11/2025 | By Dineshwori

Lunit and Labcorp Partner to Advance AI-Driven Digital Pathology Research

Lunit and Labcorp have collaborated to accelerate innovation in Artificial Intelligence (AI)-driven digital pathology, combining Labcorp’s clinical and pathology expertise with Lunit’s advanced AI technologies to enhance tumour microenvironment analysis and support next-generation oncology research.

Digitalization | 20/11/2025 | By Dineshwori

GSK, Fleming Initiative Launch AI-Driven Grand Challenges to Target AMR

These initiatives bring together leading scientific expertise and advanced technologies—including AI—to tackle urgent gaps in antibiotic discovery, fungal infection treatment, immune response understanding, disease prediction, clinical prescribing, and global policy engagement.

Digitalization | 19/11/2025 | By Darshana

Uhlmann Pac-Systeme Wins Allianz Industry 4.0 Award for AI-Based SmartAssist System

Uhlmann Pac-Systeme has been honoured with the Allianz Industrie 4.0 Award for its AI-driven assistance system, Uhlmann SmartAssist, which supports employees in setting up complex, customer-specific pharmaceutical packaging machines.

Digitalization | 15/11/2025 | By Dineshwori

AI Adoption in Pharma Supply Chains Shifts from Monitoring to Predictive Intelligence: LogiPharma 2025 Report

LogiPharma, the world’s largest end-to-end life sciences supply chain event, has unveiled its 2025 Artificial Intelligence Report, revealing a major transition in how pharmaceutical companies are adopting AI technologies.

Digitalization | 13/11/2025 | By Darshana

Harbour BioMed and Evinova Partner to Advance AI-Driven Biologics Development

Harbour BioMed (HBM), a global biopharmaceutical company focused on innovative antibody therapeutics in immunology and oncology, has entered into a strategic collaboration with Evinova, a global health-tech company dedicated to advancing digital health solutions for the life sciences sector.

Digitalization | 10/11/2025 | By Darshana

Harbour BioMed and Evinova China Partner to Accelerate AI-Enabled Drug Development

Under the agreement, Harbour BioMed and Evinova China will combine their respective strengths to build an open ecosystem for AI-driven drug research and development.

Digitalization | 07/11/2025 | By Dineshwori

Tenthpin Launches Centre for Lifesciences Cloud Solutions in Pune

Tenthpin’s Centre for Lifesciences Cloud Solutions will develop and deploy future-ready cloud solutions for pharmaceutical, medtech, biotech, healthcare, animal health, and CDMO sectors, enabling regulatory compliance, real-time insights, seamless data integration, and enhanced collaboration across the global value chain.

Digitalization | 07/11/2025 | By Dineshwori

Lilly Partners with NVIDIA to Build AI Supercomputer for Drug Discovery and Delivery

Eli Lilly has partnered with NVIDIA to build AI supercomputer, aimed at accelerating the discovery and delivery of new medicines. The collaboration will leverage advanced AI capabilities to identify, optimise, and validate novel molecules, with additional applications in manufacturing, medical imaging, and enterprise AI solutions.

Digitalization | 31/10/2025 | By Dineshwori |  115

Bahrain's sovereign fund partners with SandboxAQ to accelerate AI-driven drug discovery

Bahrain’s sovereign wealth fund, Mumtalakat, has entered into a strategic partnership with SandboxAQ, a USA-based company specialising in artificial intelligence and quantum technologies, to fast-track drug discovery and build biotech assets valued at up to USD 1 billion.

Digitalization | 28/10/2025 | By Darshana |  152